Psychemedics EVP Charles Doucot to depart Sept 15, 2023; severance per 2019 agreement

PSYCHEMEDICS CORP

Executive Vice President Charles Doucot leaving effective September 15, 2023.
Severance benefits follow terms of February 26, 2019 severance agreement.
No replacement or further executive changes announced in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Charles Doucot

Executive Vice President

PMDI · PSYCHEMEDICS CORP

Effective: 2023-09-15
Filed: August 31, 2023, 7:59 PM ET

Charles Doucot, the Company’s Executive Vice President, will be leaving the Company effective September 15, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Charles Doucot departed as Executive Vice President at PSYCHEMEDICS CORP.

Action: leaving
Role: Executive Vice President

Exact text from the filing

Charles Doucot, the Company’s Executive Vice President, will be leaving the Company effective September 15, 2023.

View on SEC.gov

PSYCHEMEDICS CORP filing history →

Source: SEC EDGAR

accession 0001171843-23-005514

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.